ChemoCentryx
CCXI
$51.99
Share price
0.00%
Change (1 day)
33.72%
Change (1 year)
Categories
ChemoCentryx (CCXI) Fails to deliver data
Key failure to deliver metrics for ChemoCentryx:
- Last SEC data release: 2023-07-14
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $8.56 M
Failures to deliver for ChemoCentryx (CCXI) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for ChemoCentryx (CCXI) - since 2013
Volume in USD (price x number of shares), data since 2013ChemoCentryx (CCXI) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2022 | $11.32 M | -86.68% |
| 2021 | $85.02 M | 119.84% |
| 2020 | $38.67 M | -10.95% |
| 2019 | $43.43 M | 1816.81% |
| 2018 | $2.26 M | 43.18% |
| 2017 | $1.58 M | 2.36% |
| 2016 | $1.54 M | 0.62% |
| 2015 | $1.53 M | -69.71% |
| 2014 | $5.07 M | -25.86% |
| 2013 | $6.84 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 AbbVie ABBV | $8.72 M | $79.91 M | 🇺🇸 USA |
 Amgen AMGN | $52.25 M | $0.21 B | 🇺🇸 USA |
 Biogen BIIB | $22.53 M | $74.47 M | 🇺🇸 USA |
 Merck MRK | $6.57 M | $0.15 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $18.31 M | $24.09 M | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | 🇮🇱 Israel |